CAMP4 THERAPEUTICS CORPORATION
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics C… Read more
CAMP4 THERAPEUTICS CORPORATION (CAMP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.132x
Based on the latest financial reports, CAMP4 THERAPEUTICS CORPORATION (CAMP) has a cash flow conversion efficiency ratio of 0.132x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($6.29 Million) by net assets ($47.70 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CAMP4 THERAPEUTICS CORPORATION - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how CAMP4 THERAPEUTICS CORPORATION's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CAMP4 THERAPEUTICS CORPORATION Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CAMP4 THERAPEUTICS CORPORATION ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Benchmark Metals Inc
V:CEI
|
0.029x |
|
Elicio Therapeutics Inc.
NASDAQ:ELTX
|
-2.905x |
|
Diamyd Medical AB (publ)
ST:DMYD-B
|
-0.189x |
|
PROTALIX BIOTHERAP.DL-01
F:PBDA
|
N/A |
|
Jiangsu Teeyer Intelligent Equipment Co.,Ltd.
SHG:603273
|
-0.011x |
|
Ginebra San Miguel Inc
PINK:GBSMF
|
0.001x |
|
DOUGLAS ELLIMAN DL-01
F:8OT
|
N/A |
|
Wecome Pharmaceutical Co Ltd
SHE:300878
|
-0.001x |
Annual Cash Flow Conversion Efficiency for CAMP4 THERAPEUTICS CORPORATION (1989–2025)
The table below shows the annual cash flow conversion efficiency of CAMP4 THERAPEUTICS CORPORATION from 1989 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $47.70 Million | $-29.55 Million | -0.620x | +14.14% |
| 2024-12-31 | $63.14 Million | $-45.56 Million | -0.722x | -302.19% |
| 2023-12-31 | $-123.73 Million | $-44.16 Million | 0.357x | -28.21% |
| 2022-12-31 | $-77.53 Million | $-38.54 Million | 0.497x | +1045.01% |
| 2021-12-31 | $80.18 Million | $-4.22 Million | -0.053x | -118.28% |
| 2020-12-31 | $99.32 Million | $28.59 Million | 0.288x | +243.86% |
| 2019-12-31 | $137.92 Million | $11.54 Million | 0.084x | -63.94% |
| 2018-12-31 | $205.65 Million | $47.74 Million | 0.232x | -30.97% |
| 2017-12-31 | $198.92 Million | $66.89 Million | 0.336x | +113.79% |
| 2016-12-31 | $164.00 Million | $25.80 Million | 0.157x | -37.13% |
| 2015-12-31 | $189.45 Million | $47.40 Million | 0.250x | +32.23% |
| 2014-12-31 | $151.38 Million | $28.64 Million | 0.189x | +10.42% |
| 2013-12-31 | $133.15 Million | $22.82 Million | 0.171x | +21.37% |
| 2012-12-31 | $117.55 Million | $16.60 Million | 0.141x | -71.63% |
| 2011-12-31 | $24.98 Million | $12.43 Million | 0.498x | +922.31% |
| 2010-12-31 | $17.60 Million | $857.00K | 0.049x | -62.19% |
| 2009-12-31 | $19.20 Million | $2.47 Million | 0.129x | -78.29% |
| 2008-12-31 | $23.20 Million | $13.76 Million | 0.593x | +3050.37% |
| 2007-12-31 | $73.42 Million | $-1.48 Million | -0.020x | -118.18% |
| 2006-12-31 | $151.25 Million | $16.72 Million | 0.111x | -13.00% |
| 2005-12-31 | $176.11 Million | $22.38 Million | 0.127x | +60.46% |
| 2004-12-31 | $158.29 Million | $12.54 Million | 0.079x | +1.62% |
| 2003-12-31 | $65.36 Million | $5.09 Million | 0.078x | -16.61% |
| 2002-12-31 | $58.62 Million | $5.48 Million | 0.093x | -71.47% |
| 2001-12-31 | $37.58 Million | $12.31 Million | 0.328x | +32.12% |
| 2000-12-31 | $30.28 Million | $7.51 Million | 0.248x | +2277.78% |
| 1999-12-31 | $28.09 Million | $293.00K | 0.010x | -96.49% |
| 1998-12-31 | $20.20 Million | $6.00 Million | 0.297x | +114.85% |
| 1997-12-31 | $21.70 Million | $3.00 Million | 0.138x | +162.86% |
| 1996-12-31 | $24.10 Million | $-5.30 Million | -0.220x | -148.89% |
| 1995-12-31 | $22.90 Million | $10.30 Million | 0.450x | +97.11% |
| 1994-12-31 | $14.90 Million | $3.40 Million | 0.228x | +1027.96% |
| 1993-12-31 | $12.20 Million | $-300.00K | -0.025x | -107.80% |
| 1992-12-31 | $7.30 Million | $2.30 Million | 0.315x | -22.28% |
| 1991-12-31 | $3.70 Million | $1.50 Million | 0.405x | +170.27% |
| 1990-12-31 | $2.00 Million | $300.00K | 0.150x | +50.00% |
| 1989-12-31 | $2.00 Million | $200.00K | 0.100x | -- |